Jeng YM - Search Results

1

Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma.

Liao SH, Su TH, Jeng YM, Liang PC, Chen DS, Chen CH, Kao JH. Liao SH, et al. Among authors: jeng ym. Hepatology. 2019 Jan;69(1):209-221. doi: 10.1002/hep.30162. Hepatology. 2019. PMID: 30014620

2

Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.

Liu SH, Lin CY, Peng SY, Jeng YM, Pan HW, Lai PL, Liu CL, Hsu HC. Liu SH, et al. Among authors: jeng ym. Am J Pathol. 2002 May;160(5):1831-7. doi: 10.1016/S0002-9440(10)61129-7. Am J Pathol. 2002. PMID: 12000734 Free PMC article.

3

Mutation of the DR5/TRAIL receptor 2 gene is infrequent in hepatocellular carcinoma.

Jeng YM, Hsu HC. Jeng YM, et al. Cancer Lett. 2002 Jul 26;181(2):205-8. doi: 10.1016/s0304-3835(02)00051-4. Cancer Lett. 2002. PMID: 12175536

4

P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.

Chen YW, Jeng YM, Yeh SH, Chen PJ. Chen YW, et al. Among authors: jeng ym. Hepatology. 2002 Oct;36(4 Pt 1):927-35. doi: 10.1053/jhep.2002.36126. Hepatology. 2002. PMID: 12297840

5

Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients.

Liu CJ, Chen PJ, Lai MY, Kao JH, Jeng YM, Chen DS. Liu CJ, et al. Among authors: jeng ym. Hepatology. 2003 Mar;37(3):568-76. doi: 10.1053/jhep.2003.50096. Hepatology. 2003. PMID: 12601355

6

Overexpression and amplification of Aurora-A in hepatocellular carcinoma.

Jeng YM, Peng SY, Lin CY, Hsu HC. Jeng YM, et al. Clin Cancer Res. 2004 Mar 15;10(6):2065-71. doi: 10.1158/1078-0432.ccr-1057-03. Clin Cancer Res. 2004. PMID: 15041727

7

Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma.

Ni YH, Chang MH, Wang KJ, Hsu HY, Chen HL, Kao JH, Yeh SH, Jeng YM, Tsai KS, Chen DS. Ni YH, et al. Among authors: jeng ym. Gastroenterology. 2004 Dec;127(6):1733-8. doi: 10.1053/j.gastro.2004.09.048. Gastroenterology. 2004. PMID: 15578511

8

Aberrant expressions of annexin A10 short isoform, osteopontin and alpha-fetoprotein at chromosome 4q cooperatively contribute to progression and poor prognosis of hepatocellular carcinoma.

Peng SY, Ou YH, Chen WJ, Li HY, Liu SH, Pan HW, Lai PL, Jeng YM, Chen DC, Hsu HC. Peng SY, et al. Among authors: jeng ym. Int J Oncol. 2005 Apr;26(4):1053-61. Int J Oncol. 2005. PMID: 15754002

9

Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.

Yuan RH, Jeng YM, Chen HL, Hsieh FJ, Yang CY, Lee PH, Hsu HC. Yuan RH, et al. Among authors: jeng ym. Clin Cancer Res. 2005 Apr 1;11(7):2568-75. doi: 10.1158/1078-0432.CCR-04-2039. Clin Cancer Res. 2005. PMID: 15814635

10

Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.

Liu CJ, Jeng YM, Chen PJ, Lai MY, Yang HC, Huang WL, Kao JH, Chen DS. Liu CJ, et al. Among authors: jeng ym. Antivir Ther. 2005;10(3):405-15. Antivir Ther. 2005. PMID: 15918331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters